THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, will make presentations at two scientific meetings in Australia in June that demonstrate significant advancement of Opexa’s human stem cell program to develop human monocyte-derived stem cell therapies for the treatment of human diseases such as diabetes.
